Extractions: Purpose: The targeted cytotoxic somatostatin analogue AN-238, consisting of 2-pyrrolinodoxorubicin (AN-201) linked to carrier octapeptide RC-121, is scheduled for clinical trials. To extend previous findings we tested AN-238 on human androgen sensitive MDA-PCa-2b prostate cancers grown subcutaneously and androgen independent LNCaP derived C4-2 prostate cancers xenografted into the tibiae of nude mice. Materials and Methods: Changes in serum prostate specific antigen (PSA) levels were monitored by radioimmunoassay. Somatostatin receptors in tumor samples were characterized. Results: Three intravenous injections of AN-238 at 150 nmol/kg doses inhibited the growth of subcutaneous MDA-PCa-2b tumors by 62% vs controls (p <0.05) and were more effective than equimolar doses of the radical AN-201 (p
Extractions: Abstract PDF (471 K) References (35) View full size inline images The Journal of Urology Volume 163(2) February 2000 p 623 HALMOS, GABOR; ARENCIBIA, JOS M.; SCHALLY, ANDREW V. ; DAVIS, RODNEY; BOSTWICK, DAVID G. From the Endocrine, Polypeptide and Cancer Institute, Veterans Affairs Medical Center, and the Departments of Medicine and Urology, Tulane University School of Medicine, New Orleans, Louisiana; and the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota Accepted for publication August 20, 1999. Requests for reprints: Veterans Affairs Medical Center, 1601 Perdido Street, New Orleans, Louisiana 70112-1262. Supported by the Medical Research Service of the Veterans Affairs Department, and a CaP CURE Foundation Research Award. Article Outline Figures/Tables Table 1 Fig. 1
Extractions: 4) Unfortunately, if one actually follows the link to the actual UN report, the UN report includes in it's overview a section describing why all of the arab's problems are caused by Israel (and by implication the US), and, of course, no mention of terrorism. Why can't someone publish anything in the arab world that is at all critical unless it first blaming Israel for all of the problems. We have a long way to go. IQ and the Wealth of Nations All Nobel Winners - last updated in 2002 Contribution of the Muslim People 19.6% of World's Population
IngentaConnect Table Of Contents: Breast Cancer Research And Treatment Authors Andreas R. Gumlnthert; Carsten Grumlndker; Till Bongertz; Attila Nagy;andrew V. schally; Gumlnter Emons. Is expert breast pathology assessment http://www.ingentaconnect.com/content/klu/brea/2004/00000087/00000003
Holland-Frei Cancer Medicine, 6th Edition andrew V. schally and Ana Maria Comaruschally. 62. Corticosteroids Lorraine I.McKay and John A. Cidlowski. 63. Estrogens and Antiestrogens http://www.intl.elsevierhealth.com/catalogue/title.cfm?ISBN=1550092138
Nobel Prize For Medicine Sir John Eccles, Alan L. Hodgkin, andrew F. Huxley. 1964. Konrad Bloch, Feodor Lynen Roger Guillemin, andrew V. schally, Rosalyn Sussman Yalow. 1978 http://www.nndb.com/honors/214/000068010/
Extractions: This is a beta version of NNDB Search: All Names Living people Dead people Band Names Book Titles Movie Titles Full Text for Nobel Prize for Medicine HONOR Nobel Prize for Medicine. Emil von Behring Ronald Ross Niels Ryberg Finsen Ivan Pavlov Robert Koch Alphonse Laveran Ilya Mechnikov, Paul Ehrlich Theodor Kocher Albrecht Kossel Allvar Gullstrand Alexis Carrel Charles Richet (no award) (no award) (no award) (no award) Jules Bordet August Krogh (no award) Archibald V. Hill, Otto Meyerhof Frederick G. Banting, John Macleod Willem Einthoven (no award) Johannes Fibiger Julius Wagner-Jauregg Charles Nicolle Christiaan Eijkman, Sir Frederick Hopkins Karl Landsteiner Otto Warburg Sir Charles Sherrington, Edgar Adrian Thomas H. Morgan George H. Whipple, George R. Minot, William P. Murphy Hans Spemann Sir Henry Dale, Otto Loewi Corneille Heymans Gerhard Domagk (no award) (no award) (no award) Henrik Dam, Edward A. Doisy Joseph Erlanger, Herbert S. Gasser Alexander Fleming , Ernst B. Chain, Sir Howard Florey Hermann J. Muller Carl Cori, Gerty Cori, Bernardo Houssay Walter Hess, Egas Moniz
Fr.wikipedia.com/w/index.php?title=Andrew_V._Schal The Nobel prize for Medicine 1977 (Roger Guillemin, andrew V The Nobel prize for Medicine 1977 (Roger Guillemin, andrew V. schally) Articlein Dutch De Wied D. Publication Types Biography Historical Article http://fr.wikipedia.com/w/index.php?title=Andrew_V._Schally&action=edit
Entrez PubMed andrew V. schally, Nobel Prize winner, Doctor honoris causa of the MedicalAcademy in Cracow Article in Polish Kretowicz J. Publication Types Biography http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6
Current Pharmaceutical Design Home Page andrew V. schally (VAMC, New Orleans, LA, USA). George J. Schroepfer Jr. (RiceUniversity, Houston, TX, USA). Linus L. Shen (Abbott Laboratories, http://www.bentham.org/cpd/index2.html
Extractions: Drug Design Instructions for Authors Subscription View the following sample copies online Vol. 6 Issue 16 Vol. 8 Issue 2 Vol. 8 Issue 3 Online Articles: Pay-Per-View Editorial Scope Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. An Executive editor who is an acknowledged authority in a therapeutic field has solicited for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia. Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.
Francisco Gonzalez-Lima, Ph.D. During his last summer at Tulane he worked in the neuroendocrinology laboratoryof Dr. andrew V. schally, who later that year earned a Nobel Prize. http://www.psy.utexas.edu/psy/FACULTY/Gonzalez-Lima/Gonzalez-Lima.html
Academia Mexicana De Ciencias Translate this page andrew V. schally. Sección Medicina. School of Medicine, Tulane UniversityMedical Center, USA. Premio Nobel 1977. 53. Dieter Seebach. Sección Química http://www.amc.unam.mx/membresia/miembros_correspondientes.html
Academia Mexicana De Ciencias Translate this page schally, andrew V. Biología y medicina. Oncología, endocrinología. Selman Lama,Moisés Eduardo. Medicina. Neumología, biología molecular http://www.amc.unam.mx/secciones/c_med.htm
Extractions: fasalam@prodigy.net.mx Miembros de Medicina Abdullaev Jafarova, Fikrat Medicina Medicina experimental Alagón Cano, Alejandro Bioquímica Biología molecular, inmunología Alarcón Segovia, Donato Albores Saavedra, Jorge Alcocer Varela, Jorge Carlos Medicina Inmunología clínica Alemán Alemán, Víctor Biología Neurobiología, neuroquímica Alonso de Florida y Posada, Francisco Fallecido Alonso Vilatela, María Elisa Genética Neurogenética Álvarez Buylla Aldana, Ramón Fallecido Álvarez Leefmans, Francisco Javier Fisiología y biofísica Neurobiología Alvizouri Muñoz, Mario Medicina Patología experimental Aréchiga Urtuzuástegui, Hugo Hernando Fallecido Biología Neurobiología Ayala Ruíz, Aquiles Rafael Endocrinología Endocrinología reproductiva
MediaMente: Roger Guillemin Translate this page Nel 1957 inizia intanto la collaborazione con andrew V. schally al Baylor.Nel 1960 ritorna per un breve periodo in Francia per ricoprire la carica di vice http://www.mediamente.rai.it/home/bibliote/biografi/g/guillemin.htm
Extractions: Il Nobel per la medicina Roger Guillemin, che è stato in Italia per partecipare all'iniziativa "Dieci Nobel per il futuro: Scienza, economia, etica per il prossimo secolo", realizzata dalla società Hypothesis, parla in questa intervista del rapporto che intercorre tra arte e scienza e delle nuove prospettive aperte in questi settori dall'applicazione delle nuove tecnologie. Roger Guillemin padre della neuroendocrinologia, scienziato umanista di fama mondiale, premio Nobel nel 1977 (insieme a Rosalyn S. Yalow e Andrew V. Schally) per gli studi sul controllo ormonale dell'ipofisi, è oggi riconosciuto anche come artista di successo. Nato a Digione, in Francia, l'11 gennaio 1924 si laurea in medicina nel 1949 a Lione dove lavora, per circa due anni, presso il laboratorio di anatomia generale. Conosce, sempre a Lione, Hans Selye, studioso dello stress e lo segue a Montreal, in Canada. Dopo aver discusso la sua tesi di laurea, a Lione, torna in America, dove coltiva anche una forte passione per la storia della medicina. Nel 1953 ottiene il Ph. D. in fisiologia e lascia il laboratorio di Selye per il Baylor University College of Medicine di Houston, dove insegnerà fisiologia fino al 1970. Nel 1963 acquisisce la cittadinanza americana. Nel 1957 inizia intanto la collaborazione con Andrew V. Schally al Baylor. Nel 1960 ritorna per un breve periodo in Francia per ricoprire la carica di vice direttore del Laboratorio di Endocrinologia sperimentale del Collège de France ma, non soddisfatto dell'andamento della ricerca, torna in America tre anni più tardi.
Bearbeiten Von Andrew V. Schally - Seite Bearbeiten - Wikipedia ANP Pers Supportandrew V. schally and his group at Tulane University with this exciting newapproach for the andrew V. schally, Professor of Medicine and Head, http://de.wikipedia.org/?title=Andrew_V._Schally&action=edit
Medical Science Monitor - Content andrew V. schally (New Orleans) Bettie S. Siler Masters (San Antonio) HelmutSinzinger (Vien) Jacek Sieradzki (Cracow) Jerzy Stachura (Cracow) http://www.medscimonit.com/medscimonit/modules.php?name=Content&pa=showpage&pid=
Extractions: Scientists at UB and Tulane University have, for the first time, optically tracked in real-time the pathway of one of the most widely used cancer drugs linked to a peptide hormone carrier as it is being taken up by a human breast-cancer cell. The research, published in the current issue of Proceedings of the National Academy of Sciences, demonstrates the power and utility of new photonic materials developed at UB that have allowed scientists this first-ever, bird's-eye view of the cellular pathway of the chemotherapeutic agent. The compound used was AN-152, a combination of the commonly prescribed chemotherapeutic agent doxorubicin, which is linked to an LH-RH (luteinizing hormone-release hormone) analog that targets only cells with LH-RH receptors on them. This makes the compound specific to cancers of the ovary, breast, cervix and prostate, and possibly others as well. AN-152, now in animal trials, was first synthesized by Andrew V. Schally, 1977 Nobel laureate in medicine and director of the Endocrine, Polypeptide and Cancer Institute of the Veterans Affairs Medical Center in New Orleans, and Attila Nagy, associate professor of medicine at Tulane University School of Medicine. Both are co-authors on the paper.
Extractions: HOME HELP FEEDBACK SUBSCRIPTIONS ... TABLE OF CONTENTS This Article Full Text Full Text (PDF) Submit a related Letter to the Editor ... Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal ... Cited by other online articles PubMed PubMed Citation Articles by Chatzistamou, I. Articles by Halmos, G. Ioulia Chatzistamou Andrew V. Schally Jozsef L. Varga Kate Groot Patricia Armatis Rebeca Busto and Gabor Halmos Endocrine, Polypeptide, and Cancer Institute, Veterans Affairs Medical Center (I.C., A.V.S., J.L.V., K.G., P.A., R.B., G.H.), and Section of Experimental Medicine, Department of Medicine, Tulane University School of Medicine (I.C., A.V.S., J.L.V., R.B., G.H.), New Orleans, Louisiana 70112 Address all correspondence and requests for reprints to: Dr. Andrew V. Schally, Endocrine, Polypeptide, and Cancer Institute, Veteran Affairs Medical Center, 1601 Perdido Street, New Orleans, Louisiana 70112-1262.
Extractions: HOME HELP FEEDBACK SUBSCRIPTIONS ... TABLE OF CONTENTS This Article Full Text Full Text (PDF) Submit a related Letter to the Editor ... Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal ... Cited by other online articles PubMed PubMed Citation Articles by Schally, A. V. Kate Groot Rhonda D. Kineman William R. Robinson and Andrew V. Schally Endocrine, Polypeptide, and Cancer Institute, Veterans Affairs Medical Center, and the Department of Medicine (Z.K., J.M.A., V.J.C., K.G., A.V.S.), Section of Gynecologic Oncology, Tulane Cancer Center (W.R.R.), Tulane University School of Medicine, New Orleans, Louisiana 70112; and the Department of Medicine, University of Illinois (R.D.K.), Chicago, Illinois 60612 Address all correspondence and requests for reprints to: Dr. Andrew V. Schally, Veterans Administration Medical Center, 1601 Perdido Street, New Orleans, Louisiana 70112-1262.
Academia Nacional De Medicina Translate this page Dr. andrew V. schally (Estados Unidos). Dirección VA Medical Center Room 7F1091601 Perdido St. New Orleáns, LA 70124 USA Tel (001) 504-589-5230 http://www.anm.org.ve/psitem.cfm?psid=444&d=prodshow
